Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

A multicenter study to evaluate the analgesic efficacy of XP21L in subjects with pain following bunionectomy surgery.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Xanodyne Pharmaceuticals
• Treatments: Analgesics; Diclofenac

Criteria

Inclusion Criteria:

• 18-65 years of age

• Have undergone bunionectomy surgery

• Have achieved adequate post-surgical pain

Exclusion Criteria:

• Confounding medical conditions which preclude study participation

• Participated in a study of another investigational drug or device within 30 days prior to randomization